CC-98633 is a BCMA targeted Chimeric Antigen Receptor (CAR) T Cell therapy that is being evaluated in multiple myeloma.
| SparkCures ID | 381 |
|---|---|
| Developed By | Juno Therapeutics, a Subsidiary of Celgene |
| Generic Name | CC-98633 |
| Treatment Classifications | |
| Treatment Targets |
There are no resources, links or videos to display for this treatment.